In this issue:
Anti-sclerostin antibody AMG 785
Odanacatib improves BMD
BMD changes and fracture prediction
Antihypertensive drugs and hip fracture risk
Non-benzodiazepine hypnotics and hip fracture risk
Duration and safety of osteoporosis therapy
Osteocalcin regulates bone formation via the CNS
Denosumab + teriparatide improve BMD
Calcium supplements and CV disease risk
Oestrogen deficiency mediates bone loss in hypogonadal men
Bone loss after bariatric surgery
Please login below to download this issue (PDF)